Drug Search Results
More Filters [+]


Alternative Names: methyltestosterone, android, methyl testosterone, oreton, virilon, metandren, testred, methitest
Latest Update: 2024-06-11
Latest Update Note: News Article

Product Description

Methyltestosterone is a methylated synthetic androgen receptor agonist with anabolic effects. Methyltestosterone, mimicking testosterone, binds to cytosolic androgen receptors, and the subsequent nuclear transfer of the ligand-receptor complex induces transcription initiation of androgen responsive genes.  (Sourced from: https://pubchem.ncbi.nlm.nih.gov/compound/Methyltestosterone)

Mechanisms of Action: AR Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Argentina | Australia | Brazil | Canada | Chile | Hong Kong | India | Ireland | New Zealand | Pakistan | Peru | Russia | Taiwan | Turkey | United Kingdom | United States | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Methyltestosterone

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases



Trial Status


Primary Completion Date

Probability of Success

Recent News Events